Genomadix

Leading the pharmacogenetics market Align with the guidelines CYP2C19 genotyping to guide dual antiplatelet therapy decision making, is now included in the new AHA/ASA guideline for Early Management of Patients with Acute Ischemic Stroke New AHA/ASA Guideline Same Treatment Different People…

Health and bio

Latest funding

Seed · July 20, 2022

Amount not disclosed in a source on record.

Funding history ↓

Website: genomadix.com.

Category: Health and bio.

Stage: Seed.

Last round: Jul 20, 2022 · 1,576 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredSep 9, 2021 (5 years old)

Funding rounds

July 20, 2022
Seed · amount undisclosed
Source: fundraisingfox.com
September 9, 2021
Website created

Companies like Genomadix

PPerfuze$26M Series A · Feb 2022
EEmboline$20M · Mar 2026
TTime Is Brain$3.42M Series A · Jul 2026
BBioliberty$3.3M Series A · Nov 2026
NNeubond$1.97M Seed · Jun 2026
AAvidicure$50M Seed · Jun 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/genomadix (get a free API key).